Tag:
Alli
Latest Headlines
Latest Headlines
UPDATED: Alli sale still held hostage by Roche GMP issues
GlaxoSmithKline has buyers interested in taking the diet drug Alli off its hands, if Roche could just get its manufacturing issues fixed.
GSK offloads consumer brands to Omega, delays Alli sale
GlaxoSmithKline's ( $GSK ) good news: It has found a buyer for European rights to a portfolio of consumer products it has been trying to unload for some time. The not-so-good: It's still stuck with Alli, the weight-loss drug, as supply problems weigh on its ability to market the brand.
Omega gets German plant as part of OTC deal with GSK
Omega Pharma will get GlaxoSmithKline's ( $GSK ) manufacturing plant in Herrenberg, Germany, as part of the $612 million acquisition of GSK's over-the-counter healthcare brands in Europe.
GSK impatient to unload for-sale OTC brands
GlaxoSmithKline ( $GSK ) wants to make a deal already. After hawking a portfolio of consumer drugs for months, the company managed to unload 17 of them to Prestige Brands Holdings in December. Now, it
Euro woes, Alli questions weigh on GSK sale
GlaxoSmithKline ( $GSK ) can thank Greece and Angela Merkel if its attempt to sell an OTC drug portfolio stalls. Europe's inability to get its act together is frustrating some M&A, as satisfactory
Alli counterfeiter gets 87 months
Shengyang Zhou, of Yunnan, China, has been given 87 months in federal prison and fined more than $500,000. Zhou pleaded guilty in January to trafficking and importing counterfeit Alli, the
Weight-loss meds get liver-injury warning
The FDA is slapping new liver-injury warnings on the weight-loss drugs Xenical and Alli. The decision comes after a safety review at the agency, prompted by reports of liver problems among patients
GSK, FDA fight diet-pill fakes
Drug giant GlaxoSmithKline is fighting counterfeiters who have targeted its over-the-counter weight-loss product, Alli. The fakes contain sibutramine rather than the drug's active ingredient,
Glaxo troubled by flu cuts, fake Alli
No sooner had GlaxoSmithKline been hit with H1N1 flu disappointments than another problem surfaced: counterfeit versions of its weight-loss product Alli. The difference is that the flu vaccine and
Glaxo gets into film biz with documentary
Glaxo goes to Hollywood. The company is producing a "hard-hitting" documentary to educate folks about obesity--and increase awareness of its weight-loss drug Alli, the New York Times reports. An
